2m 2m 2m 2m 2m 2m 2m
Coherus Onco (CHRS)
NASDAQ
$1.44+$0.03 (+1.77%)
Price as of Aug 03, 2026 11:33 AM EDT- $217.5MMarket Cap
- 60.63%1-Year Change
- BiotechnologyIndustry
Coherus Onco (CHRS)
$1.44+$0.03 (+1.77%)
CHRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.41 | ||
Change | -$0.06 (-4.08%) | ||
Open | $1.48 | ||
High | $1.48 | ||
Low | $1.40 | ||
Previous Close | $1.47 | ||
Volume | 437,181 | ||
30-Day Average Volume | 700,903 | ||
1-Week Change | 0.00% | ||
1-Month Change | 0.71% | ||
1-Year Change | 60.63% | ||
3-Year Change | -70.75% | ||
5-Year Change | -89.20% | ||
Fundamentals | |||
Shares Outstanding | 154.2M | ||
Total Assets | $266.0M | ||
Market Cap | $217.5M | ||
Enterprise Value | $139.4M | ||
Period: QTR TTM FY | |||
Revenue | $12.3M | ||
Net Income | -$38.3M | ||
Free Cash Flow | -$57.9M | ||
EBIT | -$36.1M | ||
EBITDA | -$35.3M | ||
Net Working Capital | $73.7M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 3 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue